MEM Memphasys Ltd
- 0.009
- +0.001+12.50%
Memphasys Ltd News
Memphasys Ltd Gains Momentum in Global Markets
Memphasys Secures Additional Order for Fertility Device System in Japan; Shares Jump 9%
Memphasys (ASX:MEM) secured an order for its Felix fertility device system with Vitrolife Japan, a subsidiary of Swedish medical distributor Vitrolife Group, according to a filing with the Australian
Memphasys Completes Trial of Animal Fertility System
Memphasys (ASX:MEM) completed a field trial of its artificial insemination port system consisting of four bulls and 146 cows at a stud farm in New South Wales. The system was able to reach 60% of the
Memphasys' Entitlement Offer Undersubscribed
Memphasys' (ASX:MEM) non-renounceable entitlement offer incurred a shortfall of 158.9 million rights, the reproductive biotechnology firm said on Friday. Of the 213.2 million rights offered, only 54.3
Memphasys Accelerates Commercial Approval for Sperm-separation Device
Despite innovative technology, Memphasys (ASX:MEM) has been swimming against the tide in recent times. But with the company poised to bank $4.23 million in a capital raising and having signed expanded
Memphasys Signs Distribution Deals for Fertility System; Shares Jump 8%
Memphasys (ASX:MEM) signed a deal with subsidiaries of Swedish in vitro fertilization firm Vitrolife to distribute the Felix reproductive system in the markets of Canada and New Zealand. First orders
Memphasys Receives AU$1.3 Million R&D Tax Rebate
Memphasys (ASX:MEM) received a research and development tax refund of about AU$1.3 million. The tax rebate will be used to repay an R&D loan to Radium Capital and to fund the continued development and
India Records 10 More Live Births Using Memphasys' Fertility Device
Memphasys' (ASX:MEM) Felix system fertility device played an integral role in 10 recent live births in India, the medical device firm said on Friday. The live births were reported by the medical devic
Vitrolife Japan Places Initial Order for Memphasys' Felix System
Vitrolife Japan KK, a subsidiary of the Swedish-based Vitrolife Group, placed its first order for Memphasys' (ASX:MEM) reproductive device Felix system under its exclusive agreement to sell and distri
Memphasys Signs Exclusive Japan Distribution Deal for Reproductive Device; Shares Surge 23%
Memphasys (ASX:MEM) signed an exclusive deal for the distribution and sale of its reproductive device Felix system in the Japanese market with partner in-vitro fertilization supplier Vitrolife Japan,
Memphasys Secures Two New Australian Patents for the Felix System
The Australian Patent Office granted Memphasys (ASX:MEM) two new patents for the Felix system, the reproductive biotechnology company said Thursday. The acquisition of the two new patents boosts Memph
A Memphasys Limited (ASX:MEM) Insider Increased Their Holdings by 6.2% Last Year
Analysis
Price Target
No Data
